Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients

NCT07637474 · clinicaltrials.gov ↗
RECRUITING
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Regina Elena Cancer Institute

Collaborators